Results 271 to 280 of about 71,002 (280)

Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors

Pharmacological Research, 2002
Lucio Tentorí, Grazia Graziani
exaly  

Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory Neuropathy

Diabetes, 2006
Viktor R Drel, Pal Pacher, Mark A Yorek
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)

Bioorganic and Medicinal Chemistry Letters, 2010
Seong-Ho Koh, Seung Hyun Kim
exaly  

Poly(ADP-ribose) polymerase inhibitors: toxicity and costs

PharmacoEconomics & Outcomes News, 2020
openaire   +2 more sources

Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors

Bioorganic and Medicinal Chemistry Letters, 2010
Rita Scarpelli, Michael Rowley
exaly  

Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors

FEBS Letters, 2005
exaly  

Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase

Bioorganic and Medicinal Chemistry Letters, 2007
exaly  

Synthesis of 3-Substituted Benzamides and 5-Substituted Isoquinolin-1(2H)-ones and Preliminary Evaluation as Inhibitors of Poly(ADP-ribose)polymerase (PARP)

Bioorganic and Medicinal Chemistry, 1998
exaly  

Towards Selective Poly-ADP-ribose Polymerase Inhibitors

2019
openaire   +1 more source